Catalent
CTLT
#1739
Rank
ยฃ8.64 B
Marketcap
ยฃ47.62
Share price
0.00%
Change (1 day)
8.82%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): -ยฃ5.08

According to Catalent's latest financial reports the company's current EPS (TTM) is -ยฃ4.75. In 2023 the company made an earnings per share (EPS) of -ยฃ5.10 a decrease over its 2022 EPS that were of ยฃ1.70.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-ยฃ5.08-0.35%
2023-ยฃ5.10-399.56%
2022ยฃ1.70-30.58%
2021ยฃ2.4579.67%
2020ยฃ1.37114.12%
2019ยฃ0.64-15%
2018ยฃ0.7575.44%
2017ยฃ0.43-22.97%
2016ยฃ0.56-59.56%
2015ยฃ1.37282.05%
2014ยฃ0.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
-ยฃ0.25-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-ยฃ0.56-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
-ยฃ4.47-5.85%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
-ยฃ1.11-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA